For: | Soriano-Ursúa MA, Cordova-Chávez RI, Farfan-García ED, Kabalka G. Boron-containing compounds as labels, drugs, and theranostic agents for diabetes and its complications. World J Diabetes 2024; 15(6): 1060-1069 [PMID: 38983826 DOI: 10.4239/wjd.v15.i6.1060] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v15/i6/1060.htm |
Number | Citing Articles |
1 |
Gulali Aktas. Advances in Theranostic Approaches and Emerging Biomarkers of Diabetes Mellitus. Diagnostics 2024; 14(19): 2207 doi: 10.3390/diagnostics14192207
|
2 |
Duygu Yüksel, Mehmet Başeğmez, Fahriye Kan. The Protective Effect of Boric Acid Against High Fructose-Induced Liver and Kidney Damage in Rats. Biological Trace Element Research 2025; doi: 10.1007/s12011-025-04542-z
|
3 |
Haseeb Khaliq. Exploring the role of boron-containing compounds in biological systems: Potential applications and key challenges. Journal of Trace Elements in Medicine and Biology 2025; 87: 127594 doi: 10.1016/j.jtemb.2025.127594
|
4 |
Marvin A. Soriano-Ursúa, Marlet Martínez-Archundia, Ahmet Kilic, Teresa Pérez-Capistran, Miriam A. Hernández-Zamora, Juan E. López-Ramos, Eunice D. Farfán-García. Formulations with Boric Acid or Aryl-Organoboron Compounds for Treating Diabetic Foot Ulcers. Scientia Pharmaceutica 2025; 93(1): 14 doi: 10.3390/scipharm93010014
|